NCT03858751View on ClinicalTrials.gov

Pharmacological Activation of HMN for OSA Aim 2

PHASE1/PHASE2RecruitingINTERVENTIONAL
Enrollment

16

Participants

Timeline

Start Date

March 1, 2019

Primary Completion Date

November 30, 2022

Study Completion Date

December 31, 2022

Conditions
Obstructive Sleep Apnea
Interventions
DRUG

Placebo oral capsule

Placebo capsule before bedtime

DRUG

LTM1201AZ

LTM1201AZ oral capsule before sleep

DRUG

LTM1201AT

LTM1201AT oral capsule before sleep

DRUG

LTM1201AG

LTM1201AG oral capsule before sleep

DRUG

LTM1201AD

LTM1201AD oral capsule before sleep

Trial Locations (1)

02115

RECRUITING

Brigham and Women's Hospital, Boston

All Listed Sponsors
lead

Brigham and Women's Hospital

OTHER